Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TITANIC-XV Trial: Prospective, Multicenter and Randomized Trial (Bioactive Bare Metal Titanium Stent Versus Everolimus Drug Eluting Stent)

NCT01510509 is registered in ClinicalTrials.gov with Hospital Universitario Infanta Cristina as lead sponsor.

NCT NCT01510509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01510509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TITANIC-XV Trial: Prospective, Multicenter and Randomized Trial (Bioactive Bare Metal Titanium Stent Versus Everolimus Drug Eluting Stent)
Lead sponsor
Hospital Universitario Infanta Cristina
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2009
Completion date
Not reported
Enrollment
Not reported
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, percutaneous coronary intervention